| Anthony Zaldonis, MD | |
|
44 Dale Rd, Prime Healthcare, Avon, CT 06001-3612 | |
| (860) 674-8830 | |
| (860) 674-8984 |
| Full Name | Anthony Zaldonis |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 45 Years |
| Location | 44 Dale Rd, Avon, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144207853 | NPI | - | NPPES |
| 001229665 | Medicaid | CT | |
| 022966 | Other | CO | MEDICAL LICENSE |
| 010022966CT01 | Other | CT | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 022966 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Francis Hospital & Medical Center | Hartford, CT | Hospital |
| Johnson Memorial Hospital | Stafford springs, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Prime Healthcare, Pc | 6709787930 | 80 |
News Archive
CancerGuide Diagnostics™, Inc. today announced that it has entered into a research collaboration and licensing agreement with Duke University to discover and develop tests to support individualized cancer treatment decisions.
Dow Jones Newswires/The Wall Street Journal on Severin Schwan, chief executive of Swiss pharmaceutical company Roche Holding AG: "'It is difficult to gauge the impact of the planned U.S. healthcare reform on the pharmaceutical industry,' Schwan told reporters at a media conference to detail 2009 earnings. 'On the one hand, more U.S. citizens will be getting access to healthcare, which is positive. At the same time, pressure on drug prices will certainly increase,' he added." The wire service adds that he also said "decisions on generic biosimilars will be key" (Greil, 2/3).
Half of U.S. first-year medical students are female, yet a new UCLA study shows that they volunteer for leadership roles in the classroom significantly less than their male counterparts. Subtle encouragement from teachers, however, can even out the playing field by boosting female students' willingness to identify themselves as leaders.
Patients with advanced ovarian cancer who undergo intensive treatment with chemotherapy that bathes the abdomen are significantly more likely to live longer than those who receive standard intravenous (IV) chemotherapy, according to a study that analyzed long-term follow-up from two landmark Gynecologic Oncology Group (GOG) trials comprising 876 patients.
› Verified 8 days ago
| Entity Name | Prime Healthcare, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184819302 PECOS PAC ID: 6709787930 Enrollment ID: O20040121000411 |
News Archive
CancerGuide Diagnostics™, Inc. today announced that it has entered into a research collaboration and licensing agreement with Duke University to discover and develop tests to support individualized cancer treatment decisions.
Dow Jones Newswires/The Wall Street Journal on Severin Schwan, chief executive of Swiss pharmaceutical company Roche Holding AG: "'It is difficult to gauge the impact of the planned U.S. healthcare reform on the pharmaceutical industry,' Schwan told reporters at a media conference to detail 2009 earnings. 'On the one hand, more U.S. citizens will be getting access to healthcare, which is positive. At the same time, pressure on drug prices will certainly increase,' he added." The wire service adds that he also said "decisions on generic biosimilars will be key" (Greil, 2/3).
Half of U.S. first-year medical students are female, yet a new UCLA study shows that they volunteer for leadership roles in the classroom significantly less than their male counterparts. Subtle encouragement from teachers, however, can even out the playing field by boosting female students' willingness to identify themselves as leaders.
Patients with advanced ovarian cancer who undergo intensive treatment with chemotherapy that bathes the abdomen are significantly more likely to live longer than those who receive standard intravenous (IV) chemotherapy, according to a study that analyzed long-term follow-up from two landmark Gynecologic Oncology Group (GOG) trials comprising 876 patients.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Anthony Zaldonis, MD 30 Jordan Ln, Prime Healthcare, Wethersfield, CT 06109-1278 Ph: (860) 263-0253 | Anthony Zaldonis, MD 44 Dale Rd, Prime Healthcare, Avon, CT 06001-3612 Ph: (860) 674-8830 |
News Archive
CancerGuide Diagnostics™, Inc. today announced that it has entered into a research collaboration and licensing agreement with Duke University to discover and develop tests to support individualized cancer treatment decisions.
Dow Jones Newswires/The Wall Street Journal on Severin Schwan, chief executive of Swiss pharmaceutical company Roche Holding AG: "'It is difficult to gauge the impact of the planned U.S. healthcare reform on the pharmaceutical industry,' Schwan told reporters at a media conference to detail 2009 earnings. 'On the one hand, more U.S. citizens will be getting access to healthcare, which is positive. At the same time, pressure on drug prices will certainly increase,' he added." The wire service adds that he also said "decisions on generic biosimilars will be key" (Greil, 2/3).
Half of U.S. first-year medical students are female, yet a new UCLA study shows that they volunteer for leadership roles in the classroom significantly less than their male counterparts. Subtle encouragement from teachers, however, can even out the playing field by boosting female students' willingness to identify themselves as leaders.
Patients with advanced ovarian cancer who undergo intensive treatment with chemotherapy that bathes the abdomen are significantly more likely to live longer than those who receive standard intravenous (IV) chemotherapy, according to a study that analyzed long-term follow-up from two landmark Gynecologic Oncology Group (GOG) trials comprising 876 patients.
› Verified 8 days ago
Dr. Chi H Kim, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 100 Simsbury Rd, Suite 203, Avon, CT 06001 Phone: 860-284-5111 Fax: 860-254-5114 | |
Carol Petruff, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 44 Dale Rd, Prime Healthcare, Avon, CT 06001 Phone: 860-674-8830 Fax: 860-674-8984 | |
Marie Dam, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 35 Tower Ln, Suite 103, Avon, CT 06001 Phone: 860-921-3345 Fax: 860-201-1041 | |
Dr. Julie Ann Vernon, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 62 Northgate, Avon, CT 06001 Phone: 860-675-0542 | |
Lisa Marie Gronski, D.O. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 339 W Main St, Avon, CT 06001 Phone: 860-696-2150 Fax: 860-696-2160 | |
Paul P Stroebel, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 236 Cold Spring Road, Avon, CT 06001 Phone: 860-673-0882 |